Dyve Bioscience touts proof-of-concept study for transdermal painkiller
Dyve Bioscience this week touted data from a human proof-of-concept pilot study of its transdermal sodium bicarbonate therapy for pain reduction in people with acute gout flare. The study enrolled 24 people with a history of gout. Those in the active treatment group were given lotion containing sodium bicarbonate and menthol, while those in the placebo group were given lotion without sodium bicarbonate or menthol. Investigators told the participants to report to the clinic within 36 hours of flare onset. Get the full story at our sister site, Drug Delivery Business News. The post Dyve Bioscience touts proof-of-concept stud...
Source: Mass Device - March 22, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Pain Management Pharmaceuticals dyvebioscience Source Type: news

The USDA Forced Kittens to Become Cannibals for Research, Watchdog Report Says
A shocking watchdog report alleges that the U.S. Department of Agriculture (USDA) spent $22.5 million conducting “unnecessary and unjustifiable” research that involved killing cats and forcing “kitten cannibalism,” among other unsavory practices. The report — from the non-profit White Coat Waste Project, which opposes animal testing by the government, and former USDA scientist Jim Keen — says a large chunk of this research relates to toxoplasmosis, an illness spread by exposure to the Toxoplasma gondii parasite. As recently as 2015, the report says, the USDA purchased and killed cats and...
Source: TIME: Science - March 20, 2019 Category: Science Authors: Jamie Ducharme Tags: Uncategorized onetime Research Source Type: news

The USDA Forced Kittens to Become Cannibals for Research, Watchdog Report Says
A shocking watchdog report alleges that the U.S. Department of Agriculture (USDA) spent $22.5 million conducting “unnecessary and unjustifiable” research that involved killing cats and forcing “kitten cannibalism,” among other unsavory practices. The report — from the non-profit White Coat Waste Project, which opposes animal testing by the government, and former USDA scientist Jim Keen — says a large chunk of this research relates to toxoplasmosis, an illness spread by exposure to the Toxoplasma gondii parasite. As recently as 2015, the report says, the USDA purchased and killed cats and...
Source: TIME: Health - March 20, 2019 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized onetime Research Source Type: news

Theranica raises $35m Series B for neuromod migraine patch
Theranica Bio-Electronics said yesterday that it raised a $35 million Series B round for the Nerivio Migra neurostim patch it’s developing to treat migraine headache. Netanya, Israel-based Theranica said VC shop aMoon led the round, joined by all of its existing backers, Lightspeed Venture Partners, LionBird, Corundum Open Innovation and Takoa. The company raised an unspecified amount in its seed round back in September 2016. Theranica closed out a nearly 300-patient pivotal study last October it used to back a bid for FDA clearance that met its primary endpoint and showed “high efficacy, safety and tolerabilit...
Source: Mass Device - March 19, 2019 Category: Medical Devices Authors: Brad Perriello Tags: Featured Funding Roundup Neuromodulation/Neurostimulation Pain Management Wall Street Beat Theranica Bio-Electronics Source Type: news

Could Data Backing Implant Shift Treatment?
This study, our extensive clinical data, and the increasing number of iFuse procedures performed annually demonstrate that there is a shift in how physicians understand SI joint dysfunction and its role in causing chronic pain.” Dunn reported that more than 37,000 iFuse procedures have been performed by more 1800 surgeons in the United States and 33 other countries around the world. “There is a significant, addressable, and growing market opportunity for iFuse: we believe there are 279,000 eligible patients each year in the United States alone, translating to a $2.7 billion market opport...
Source: MDDI - March 19, 2019 Category: Medical Devices Authors: Daphne Allen Tags: Orthopedics Source Type: news

CMS: Agency Information Collection Activities: Submission for OMB Review; Comment Request
Centers for Medicare& Medicaid Services (CMS) requests comments on three information collection activities: 1) revisions to the Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) survey that removes three questions related to pain communication to avoid potential impacts on opioid prescriptions; 2) new Home and Community Based Services (HCBS) Incident Management Survey; 3) and a new section on The State Flexibility to Stabilize the Market Grant Program Reporting. Comments are due April 15, 2019. (Source: Federal Register updates via the Rural Assistance Center)
Source: Federal Register updates via the Rural Assistance Center - March 15, 2019 Category: Rural Health Source Type: news

Study finds IV and pill form of acetaminophen work equally well after hip replacement
(Hospital for Special Surgery) Pain management after surgery is a vital part of patient care. Researchers at Hospital for Special Surgery compared acetaminophen in the intravenous versus pill form as part of the overall pain management plan after hip replacement. They found that both forms worked equally well. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 12, 2019 Category: International Medicine & Public Health Source Type: news

3 common types of chronic wounds
  How do you know if your wound is chronic? The severity of your injury, as well as complications that cause significant delays in healing, are common indicators. There are also certain kinds of wounds that often end up high on the chronic scale. Here are the three most common types of chronic wounds: Infectious wounds, surgical sites and ulcers are among the most common chronic wounds. 1. Infectious wounds When infection causes significant delays in healing, the wound often becomes chronic. According to Wound Care Centers, typical signs of chronic infectious wounds include bad odors, pus drainage, dead ti...
Source: Advanced Tissue - March 7, 2019 Category: Dermatology Authors: AdvancedTissue Tags: Wound Care Wound Infection chronic wounds Source Type: news

Pacira to acquire Myoscience in $220m deal
Pacira Pharmaceuticals (NSDQ:PCRX) said today that it has signed a deal to acquire Myoscience and its pain relief device for up to $220 million. Myoscience’s iovera system is designed to safely freeze nerves while protecting surrounding tissue. As part of the deal that is slated to close by early April, Pacira plans to incorporate the iovera system into its non-opioid product portfolio. Get the full story at our sister site, Drug Delivery Business News. The post Pacira to acquire Myoscience in $220m deal appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - March 5, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Business/Financial News Mergers & Acquisitions Pain Management Wall Street Beat Myoscience Pacira Pharmaceuticals Source Type: news

Teva launches generic for Pfizer ’s Flector pain patch
Teva (NYSE:TEVA) said last week that it launched a generic version of Pfizer‘s (NYSE:PFE) Flector diclofenac epolamine patch. Using a nonsteroidal anti-inflammatory drug, the topical patch is designed to treat acute pain due to minor strains, sprains and contusions. Get the full story at our sister site, Drug Delivery Business News. The post Teva launches generic for Pfizer’s Flector pain patch appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - March 4, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Business/Financial News Drug-Device Combinations Pain Management Pharmaceuticals Wall Street Beat Pfizer Teva Pharmaceuticals Source Type: news

How NeuroMetrix seeks to better relieve pain with AI
NeuroMetrix’s Quell 2.0 [Image courtesy of NeuroMetrix]NeuroMetrix plans to add artificial intelligence to the latest iteration of its Quell transcutaneous electrical nerve stimulation (TENS) device. AI will allow Quell 2.0 to tailor treatment to each individual user, according to the Waltham, Mass.–based based company. Launched in September 2018 Quell 2.0 is 50% smaller and 20% more powerful than the original Quell, which debuted in 2015. Quell is worn on the leg regardless of the site of pain and is designed to send neural pulses to the brain that trigger a natural pain relief response in the central nervous ...
Source: Mass Device - March 1, 2019 Category: Medical Devices Authors: Nancy Crotti Tags: Big Data Featured Health Information Technology mHealth (Mobile Health) News Well Pain Management Software / IT artificial intelligence Neurometrix opioid crisis Source Type: news

Zynex names new Vice President of Sales and Marketing
ENGLEWOOD, Colo., Feb. 28, 2019 -- (Healthcare Sales & Marketing Network) -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabili... Devices, Neurology, Personnel Zynex, electrotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 28, 2019 Category: Pharmaceuticals Source Type: news

Framework for provision of pain services for adults across the UK with cancer or life limiting disease
The guidance aims to improve pain services for adults across the UK with cancer or life-limiting disease with closer integration of pain management, oncology and palliative care services. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - February 28, 2019 Category: Consumer Health News Source Type: news

FDA clears Medtronic Accurian RF nerve ablation device
Medtronic (NYSE:MDT) said today that it won 510(k) clearance from the FDA for its Accurian radiofrequency nerve ablation device for treating chronic pain. “Medtronic has a long-established track record of bringing to market improved options to support clinicians with state-of-the-art technology, like the Accurian RF ablation system, which was designed for consistency and efficiency,” pain therapies president Dr. Marshall Stanton said in prepared remarks. “Medtronic is committed to advancing the treatment of pain as we introduce new options to help patients throughout the care continuum.” “The ...
Source: Mass Device - February 27, 2019 Category: Medical Devices Authors: Brad Perriello Tags: Food & Drug Administration (FDA) Pain Management Regulatory/Compliance Medtronic Source Type: news

Attend PAINWeekEnd in Scottsdale, Arizona to Fulfill Your State ’s...
Two days of pain management for the main street practitioner on March 23-24; mingle with faculty and attendees, learn and earn up to 12.0 AMA PRA Category 1 credits for $199.(PRWeb February 27, 2019)Read the full story at https://www.prweb.com/releases/attend_painweekend_in_scottsdale_arizona_to_fulfill_your_states_ce_cme_requirement_for_opioid_related_education/prweb16114272.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 27, 2019 Category: Pharmaceuticals Source Type: news

Hopkins Nursing—No. 1 DNP, Highlights, Domestic Violence Commentary
Hopkins Nursing—No. 1 DNP, Highlights, Domestic Violence Commentary body,#bodyTable,#bodyCell{ height:100% !important; margin:0; padding:0; width:100% !important; } table{ border-collapse:collapse; } img,a img{ border:0; outline:none; text-decoration:none; } h1,h2,h3,h4,h5,h6{ margin:0; padding:0; } p{ margin:1em 0; padding:0; } a{ word-wrap:break-word; } .mcnPreviewText{ display:none !important; } .ReadMsgBody{ width:100%; } .ExternalClass{ width:100%; } .ExternalClass,.ExternalClass p,.ExternalClass span,.ExternalClass font,....
Source: Johns Hopkins University and Health Systems Archive - February 26, 2019 Category: Nursing Source Type: news

Drug manufacturer says FDA helped spark opioid epidemic after it began broadly marketing OxyContin
A drug manufacturer says the FDA helped kick-start the opioid epidemic after it changed the label of OxyContin and broadened the drug's use for long-term pain management, not just short-term (Source: the Mail online | Health)
Source: the Mail online | Health - February 26, 2019 Category: Consumer Health News Source Type: news

Kratom exposures reported to United States poison control centers: 2011-2017 - Post S, Spiller HA, Chounthirath T, Smith GA.
CONTEXT: Kratom, or Mitragyna speciosa, is a plant indigenous to Southeast Asia that has gained national attention in the United States for its increased use in the self-management of opioid withdrawal and pain, as well as for concerns about its safety. ... (Source: SafetyLit)
Source: SafetyLit - February 25, 2019 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

People with chronic pain are coping with the help of Pinterest, new study reveals
(Virginia Commonwealth University) A new study by researchers at Virginia Commonwealth University that analyzed 502 posts on Pinterest about chronic pain revealed that the social media platform is helping people with chronic pain cope by sharing self-care and pain-management tips, venting about their pain's severity, and supporting others who are similarly suffering. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 25, 2019 Category: International Medicine & Public Health Source Type: news

Using Benchmark Data as a Launching Point for Quality Improvement in EMS
EMS agencies strive to provide the best possible care and contribute to positive patient outcomes. To ensure a high level of care, many agencies implement quality improvement programs; choosing a place to start for a quality improvement initiative, however, can seem overwhelming, with so many important conditions like cardiac arrest, sepsis, stroke, overdoses, etc. With limited time and resources, it’s necessary to concentrate efforts on measures that matter and are likely to make an impact. A great place to start with quality improvement efforts is where the gold standard is known and the frequency of events isn&rsq...
Source: JEMS Operations - February 20, 2019 Category: Emergency Medicine Authors: Remle Crowe, PhD, NREMT Tags: Exclusive Articles Operations Top Story Source Type: news

Delaying pushing in labour has no benefit for women with an epidural and/or spinal for pain relief
For women having their first baby with an epidural and/or spinal anaesthetic for pain-relief, the timing of pushing after full dilatation of the cervix does not affect the numbers that achieve normal vaginal delivery. The best management for the second stage of labour is still debated. In the UK epidurals are by far the most widely used regional anaesthetic technique for pain relief in labour. In this large trial, women either pushed immediately or delayed pushing by waiting for 60 minutes. Women in the immediate group ended up pushing for slightly longer, but their labour was 30 minutes shorter overall. They also had a ...
Source: Current Awareness Service for Health (CASH) - February 18, 2019 Category: Consumer Health News Source Type: news

Trends in the medical supply of fentanyl and fentanyl analogues: United States, 2006 to 2017 - Collins LK, Pande LJ, Chung DY, Nichols SD, McCall KL, Piper BJ.
The objectives of this study were to: 1) characterize the temporal pattern of fentanyl, fentanyl anal... (Source: SafetyLit)
Source: SafetyLit - February 18, 2019 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Pregabalin vs Gabapentin: A 10-question Quiz
Gabapentin and pregabalin have become popular alternatives to opioids for pain management. See what you  really know with our quick quiz.  (Source: ConsultantLive)
Source: ConsultantLive - February 14, 2019 Category: Internal Medicine Authors: Steven King, MD, MS Tags: Pain Source Type: news

New Analysis Finds Increases in Non-Cancer Pain Prevalence and Opioid Use for Non-Cancer Pain Management Among U.S. Adults, Despite Decreases in Pain-Related Health Care Visits
Between combined years 1997/1998 and 2013/2014, the number of U.S. adults experiencing non-cancer pain increased by 25 percent, and yet during this same period there was a decrease in visits to health care providers for pain, a small decrease in prescription pain medications overall, but a large increase in the use of opioids, especially strong opioids. Individuals from the National Center for Complementary and Integrative Health, Social& Scientific Systems, and Yale University School of Medicine, Yale Center for Medical Informatics analyzed data from a national survey. (Source: NCCAM Featured Content)
Source: NCCAM Featured Content - February 14, 2019 Category: Complementary Medicine Authors: NCCIH Source Type: news

AtriCure launches CryoIce CryoSphere probe
AtriCure (NSDQ:ATRC) today launched its CryoIce CryoSphere probe in the U.S. The Mason, Ohio-based company’s CryoSphere probe is designed to block pain by temporarily ablating peripheral nerves. The device features a bendable distal shaft and an ergonomic handle that enables cardiac, thoracic and general surgeons to easily target peripheral nerves. ArtiCure’s CryoSphere technology uses a freezing method to stop nerves from sending pain signals for several months, giving the patient’s body time to heal. “The addition of the CryoSphere probe to our pain management portfolio is a major breakthroug...
Source: Mass Device - February 12, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Business/Financial News Featured Pain Management Wall Street Beat AtriCure Inc. Source Type: news

Five Reasons Your Project Might be Underestimated
One of the key benefits of being a part of a medical device consultancy is seeing numerous programs through from start to finish. I see how the project predications correlate to actuals, where the common pitfalls occur, and how those pitfalls are typically avoided by expert project managers to maximize success. There are a lot of reasons medical device projects may go overbudget, but a big one is because the project is underestimated in the first place.1 Having a project slightly exceed time and budget estimations is usually manageable, but significant overruns are not as easy to survive. Accurate budgeting and...
Source: MDDI - February 8, 2019 Category: Medical Devices Authors: Nigel Syrotuck Tags: Design Source Type: news

Cells to Society: 130 Years of Innovation / Research News
This study explores experiences related to hearing loss and barriers to hearing health care among older Korean Americans.      Read more   Aging ...
Source: Johns Hopkins University and Health Systems Archive - February 7, 2019 Category: Nursing Source Type: news

Pain management in trauma in the age of the opioid crisis - Gross JL, Perate AR, Elkassabany NM.
It is imperative to find the balance between pain control and addressing the opioid epidemic. Opioids, although effective in the acute pain management, have multiple side effects and can lead to dependence, abuse, overdose, or death. Physicians should iden... (Source: SafetyLit)
Source: SafetyLit - February 5, 2019 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Relievant back-pain device study stopped for positive results
Relievant Medsystems said it has halted enrollment in a clinical trial of its Intracept lower-back pain device due to the device’s superiority over non-surgical management. The Level I Intracept study found a “highly significant reduction” in the Oswestry Disability Index (ODI) score in patients treated with the Intracept procedure over patients in the non-surgical management arm. The trial’s independent data management committee recommended that investigators stop enrollment and offer Intracept treatment to control-arm patients, according to the Minneapolis, Minn.-based company. The inter...
Source: Mass Device - February 4, 2019 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Clinical Trials Featured Implants News Well Orthopedics Pain Management Research & Development Spinal Relievant Medsystems University of California at San Diego Source Type: news

Identification and management of adolescent gynecologic emergencies in the emergency department - Vayngortin T, Kant S, Wilson B.
In the emergency department, gynecologic complaints are common presentations for adolescent girls, who may present with abdominal pain, pelvic pain, vaginal discharge, and vaginal bleeding. The differential diagnosis for these presentations is broad, and f... (Source: SafetyLit)
Source: SafetyLit - February 4, 2019 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Opioids and cerebral physiology in the acute management of traumatic brain injury: a systematic review - Wiener J, McIntyre A, Janzen S, Mirkowski M, MacKenzie HM, Teasell R.
BACKGROUND: Following traumatic brain injury (TBI), optimization of cerebral physiology is recommended to promote more favourable patient outcomes. Accompanying pain and agitation are commonly treated with sedative and analgesic agents, such as opioids. Ho... (Source: SafetyLit)
Source: SafetyLit - February 4, 2019 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Non-pharmacological management of persistent headaches associated with neck pain: a clinical practice guideline from the Ontario Protocol for Traffic Injury Management (OPTIMa) Collaboration - C ôté P, Yu H, Shearer HM, Randhawa K, Wong JJ, Mior S, Ameis A, Carroll LJ, Nordin M, Varatharajan S, Sutton D, Southerst D, Jacobs C, Stupar M, Taylor-Vaisey A, Gross DP, Brison RJ, Paulden M, Ammendolia C, Cassidy JD, Loisel P, Marshall S, Bohay RN, Stapleton J, Lacerte M.
OBJECTIVES: To develop an evidence-based guideline for the non-pharmacological management of persistent headaches associated with neck pain (i.e., tension-type or cervicogenic). METHODS: This guideline is based on systematic reviews of high-quality... (Source: SafetyLit)
Source: SafetyLit - February 4, 2019 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Boston Scientific launches Spectra WaveWriter SCS in Europe
Boston Scientific (NYSE:BSX) said today that it launched its Spectra WaveWriter spinal cord stimulator, intended for treating chronic pain, in Europe. The Marlborough, Mass.-based company said that its Spectra WaveWriter is designed to deliver electrical pulses of varying frequency, pulse width and amplitude to the spinal cord. Boston Scientific touted the device as the first and only such system designed to provide both paresthesia-based and sub-perception therapy. Paresthesia is a low-level tingling sensation that accompanies SCS treatment for some patients; sub-perception therapy does not create paresthesia. D...
Source: Mass Device - February 1, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Neuromodulation/Neurostimulation Pain Management Boston Scientific Source Type: news

Cannabis for Chronic Pain: Not Ready for Prime Time Cannabis for Chronic Pain: Not Ready for Prime Time
What is the quality of the data on the efficacy of cannabis for pain management? This editorial examines the issues.American Journal of Public Health (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 1, 2019 Category: Consumer Health News Tags: Public Health & Prevention Journal Article Source Type: news

January 2019 Briefing - Pain Management
Here are what the editors at HealthDay consider to be the most important developments in Pain Management for January 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 1, 2019 Category: Pharmaceuticals Source Type: news

Pain-management firm SPR Therapeutics seeks to raise $20m
SPR Therapeutics has raised $8 million of a $20 million Series C round of funding that began Jan. 19, according to an SEC filing. The Cleveland-based company’s Sprint peripheral nerve stimulation (PNS) system is FDA-cleared for both chronic and acute pain, including post-operative and post-traumatic pain. The product was launched in November 2018 for treating complex regional pain syndrome, a chronic pain condition affecting the limbs that can be caused by trauma, injury or surgery. The company also recently announced that it has named Peter Staats, M.D., as its chief medical advisor. Staats brings nearly three ...
Source: Mass Device - January 31, 2019 Category: Medical Devices Authors: Nancy Crotti Tags: Bioelectronic Medicine Blog Business/Financial News Funding Roundup Neuromodulation/Neurostimulation News Well Pain Management SPR Therapeutics Source Type: news

Identification and management of adolescent gynecologic emergencies in the emergency department - Vayngortin T, Kant S.
In the emergency department, gynecologic complaints are common presentations for adolescent girls, who may present with abdominal pain, pelvic pain, vaginal discharge, and vaginal bleeding. The differential diagnosis for these presentations is broad, and f... (Source: SafetyLit)
Source: SafetyLit - January 29, 2019 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Costs Mount as Government Shutdown Drags On
As government offices and research facilities across the country remain shuttered and services delayed or interrupted, the partial government shutdown that has resulted in 800,000 federal workers being furloughed or forced to work without pay has accomplished one thing - it has set a new record for how long the President and Congress have failed to govern the country. The costs associated with the shutdown continue to grow. Beyond the pain inflicted on federal workers, contractors, and grantees, economists now estimate that the shutdown is having real and significant negative effects on Gross Domestic Product (GDP). Kevi...
Source: Public Policy Reports - January 23, 2019 Category: Biology Authors: AIBS Source Type: news

Abbott touts effective pain management, lower energy use in BurstDR SCS study results
Abbott (NYSE:ABT) late last week released results from a study of its BurstDR spinal cord stimulation technology, touting that it provided as effective pain relief as standard SCS despite providing lower-energy, intermittent stimulation known as “microdosing,” for patients with chronic intractable pain. Results from the BOLD study were presented at the 22nd Annual North American Neuromodulation Society Meeting in Las Vegas, the Chicago-area medtech company said. All patients in the BOLD trial reported experiencing pain relief with less than six hours of battery use per day while being treated with BurstDR,...
Source: Mass Device - January 23, 2019 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Featured Neuromodulation/Neurostimulation Pain Management Spinal Abbott Source Type: news

What Complications Can Gastrostomy Tubes Have?
Discussion Gastrostomy tubes (GT or GTubes) have been used to support patients for about a century. They are placed between the abdominal skin and the stomach either percutaneously or surgically. The tubes can be a standard long tube with either a bumper or inflatable balloon internally and externally they have a retention piece to hold the GT in place. A button or low profile tube are similar but extend just beyond the skin. Reasons for GT placement include: Nutritional support Hydration maintenance Medication management Aspiration avoidance Gastric stasis decompression Obstruction bypass Quality of life improvement for...
Source: PediatricEducation.org - January 21, 2019 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Pain Management and Opioid Regulation Pain Management and Opioid Regulation
This paper explores the intersection of two substantial public health challenges: reducing the burden of pain and containing the rising toll of harms associated with the use of opioid medications.American Journal of Public Health (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 18, 2019 Category: Consumer Health News Tags: Public Health & Prevention Journal Article Source Type: news

How Can Medtech Help with the Opioid Crisis?
Pain control is one of the biggest challenges facing America today, believes Dr. Peter Staats, co-founder and chief medical officer of electroCore. Chronic pain is an ongoing, debilitating problem for many patients, but for some, overuse of opioid treatments has led to addiction. Such a condition has led to an increasing number of U.S. deaths—one study published in the JAMA Network Open1 found that the percentage of all U.S. deaths attributable to opioids increased 292% between 2001 and 2016. This same study reported that in 2016, 20% of deaths of adults aged 24 to 35 years involve...
Source: MDDI - January 18, 2019 Category: Medical Devices Authors: Daphne Allen Tags: Business Source Type: news

Stimwave touts 6 month MIS SCS trial results
Stimwave today touted six-month data from a trial of its minimally invasive spinal cord stimulator system. The company’s pivotal Surf trial compared a variety of waveform options without the need for separate trial devices. Stimwave reported that in the high and low frequency groups, back and leg pain responders were more than 92% and 86%, respectively. The 100-patient study had 100% implant placement success, according to Stimwave, and no implant-related serious adverse events. Following a 30-day trial period with the implanted device and a six-month follow-up, participants experienced statistically significant impr...
Source: Mass Device - January 17, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Featured Pain Management Stimwave Source Type: news

Medtronic kicks off study for pain pump
Medtronic (NYSE:MDT) said today that it enrolled the first patient in a study to assess the use of its SynchroMed II intrathecal drug delivery system as an alternative to oral opioids. The 100-patient Embrace TDD study is slated to follow patients who have weaned off all oral opioids, in the hopes of positioning the SynchroMed II pump as a viable alternative for people with chronic intractable non-malignant primary back pain. Get the full story at our sister site, Drug Delivery Business News. The post Medtronic kicks off study for pain pump appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - January 17, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Featured Pain Management Pharmaceuticals Wall Street Beat Medtronic Source Type: news

Neuromodulation: Using the brain ’ s internal language to relieve pain
When a patient walks into Dr. Jason Yong’s clinic at Brigham & Women‘s Faulkner Hospital complaining of pain, his work has just begun. “Pain is a common symptom and it’s totally generic,” Yong explained to MassDevice. “The other thing that makes it challenging is that it’s so subjective.” After Yong exhausts the pharmaceutical possibilities for managing his patient’s pain, he turns to technological options such as implantable neuromodulation systems. Neuromod devices use electrodes to deliver stimulation directly to a patient’s brain, spinal cord or peripheral...
Source: Mass Device - January 15, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Featured Neurological Pain Management Wall Street Beat Abbott Brigham & Women's Hospital Source Type: news

Bioness launches peripheral nerve stim registry
Bioness today launched a patient registry for people using its StimRouter neuromodulation system for peripheral nerve stimulation. Starting in the first quarter of 2019, patients will be able to opt into the StimRouter Registry, according to the Valencia, Calif.-based company. Bioness’ StimRouter was launched in 2016 and the company touts it as the first neuromodulation product specifically designed to treat chronic peripheral nerve pain. The device has been implanted in more than 1,000 chronic pain patients across the U.S., according to Bioness. “The StimRouter Registry is part of a comprehensive initiative to...
Source: Mass Device - January 14, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Featured Implants Neuromodulation/Neurostimulation Pain Management Bioness Source Type: news

Podcast: Intramuscular and intravenous opioid pain relieving drugs in labour
The use of pain-relieving drugs during labour is common throughout the world, and an updated Cochrane Review from June 2018 looks at the use of a class of drugs called opioids. Lead author, Lesley Smith from Oxford Brookes University in the UK tells us what they found." For many women in labour, an epidural containing a local anaesthetic has become an increasingly popular choice for pain relief. However, not all women choose this and some give birth in places were an epidural is not available. One of alternatives is the use of an opioid drug, such as pethidine, diamorphine or meptazinol given either intramuscularly or...
Source: Cochrane News and Events - January 10, 2019 Category: Information Technology Authors: Lydia Parsonson Source Type: news

AtriCure falls despite solid Q4, 2018 prelims | Wall Street Beat
AtriCure (NSDQ:ATRC) shares took a fall today despite preliminary results for the fourth quarter and 2018 that topped estimates. The Mason, Ohio-based cardiac implant maker said it expects to post Q4 sales of $52.9 million and 2018 sales of $201.6 million, beating the consensus estimatyes on Wall Street for both periods. “We are pleased with our fourth quarter results and performance throughout 2018, as we continue our track record of strong, consistent revenue growth. We achieved many milestones and accomplishments in 2018: we completed enrollment in the Converge IDE trial, trained over 400 healthcare professio...
Source: Mass Device - January 7, 2019 Category: Medical Devices Authors: Brad Perriello Tags: Featured MassDevice Earnings Roundup Wall Street Beat AtriCure Inc. AxoGen Cerus Corp. OrthoPediatrics Corp. Sientra STAAR Surgical Co Source Type: news

Pain and Symptom Management for People with Serious Illness in the Context of the Opioid Epidemic: A Workshop
Source: National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division (HMD). Published: 11/29/2018. This workshop explored the tension between efforts to address the opioid epidemic and the resulting impact on access to pain medications for people facing serious illness. It examined the unintended consequences of the responses to the opioid epidemic for patients, families, communities, and clinicians, and considered potential policy opportunities to address them. (Video or Multimedia) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - January 4, 2019 Category: International Medicine & Public Health Source Type: news